EHA Library - The official digital education library of European Hematology Association (EHA)

ANTIBIOTIC-RESISTANT GRAM-NEGATIVE BACTERIAL INFECTIONS IN PATIENTS WITH HEMATOLOGIC MALIGNANCY
Author(s): ,
Bechiro Achouro
Affiliations:
Hematology,Farhat Hached Hospital,Sousse,Tunisia
,
Marzouk Manel
Affiliations:
Microbiology,Farhat Hached Hospital,Sousse,Tunisia
,
Hasnaoui Zeineb
Affiliations:
Hematology,Farhat Hached Hospital,Sousse,Tunisia
,
Elhadded Nihel
Affiliations:
Community Medecine,Farhat Hached Hospital,Sousse,Tunisia
,
Akoudad Asma
Affiliations:
Hematology,Farhat Hached Hospital,Sousse,Tunisia
,
Bouslema Emna
Affiliations:
Hematology,Farhat Hached Hospital,Sousse,Tunisia
,
Regaieg Haifa
Affiliations:
Hematology,Farhat Hached Hospital,Sousse,Tunisia
,
Bensayed Nesrine
Affiliations:
Hematology,Farhat Hached Hospital,Sousse,Tunisia
,
Kmira Zahra
Affiliations:
Hematology,Farhat Hached Hospital,Sousse,Tunisia
,
Zaier Monia
Affiliations:
Hematology,Farhat Hached Hospital,Sousse,Tunisia
,
Benyoussef Yosra
Affiliations:
Hematology,Farhat Hached Hospital,Sousse,Tunisia
,
Boukadida Jalel
Affiliations:
Hematology,Farhat Hached Hospital,Sousse,Tunisia
Khelif Abderrahim
Affiliations:
Hematology,Farhat Hached Hospital,Sousse,Tunisia
EHA Library. ACHOUR B. 06/09/21; 325589; EP831
Prof. Dr. BECHIR ACHOUR
Prof. Dr. BECHIR ACHOUR
Contributions
Abstract
Presentation during EHA2021: All e-poster presentations will be made available as of Friday, June 11, 2021 (09:00 CEST) and will be accessible for on-demand viewing until August 15, 2021 on the Virtual Congress platform.

Abstract: EP831

Type: E-Poster Presentation

Session title: Infections in hematology (incl. supportive care/therapy)

Background

Patients with hematologic malignancies are at high risk for infections caused by antibiotic resistant gram-negative bacteria.

Aims

This study aimed to evaluate the characteristics, antibiotic resistance patterns and prognosis of infections due to multidrug resistant (MDR) gram-negative bacteria in patients with hematologic malignancy.

Methods

Data were collected retrospectively and concerned all infections caused by MDR gram-negative in patients with hematologic malignancy from January 2010 and November 2019 in our department of hematology. Data analysis was initially performed using the univariate analysis (chi² and student test). Then, risk factors with a P<0.05 were included in the binary logistic regression model to determine the independent risk factors of mortality.

Results

In Total, 512 patients developed infections with 83 MDR gram-negative strains detected in 80 patients, most of them (68 patients) have an acute leukemia. The MDR gram-negative infection occurred in 58 patients with uncontrolled disease, and the majority of them occurred in the presence of severe neutropenia (62 episodes/74.7%). Bloodstream infection (BSI) (57episodes/68.7%) was the most common infection types. Klebsiella pneumonia was the most common Gram-negative isolates (44 episodes/53%). Complications occurred in 44 (53%) episodes. In 41 episodes, patients received an appropriate antibiotherapy. The isolated MDR gram-negative bacteria exhibited sensitivity to amikacin in 17%, imipenem in 32.5% (three isolates were resistant to colistin). Twenty-two patients died during gram-negative MDR infections. The independent risk factors influencing mortality was : qSOFA>=2. (p : 0.003) (table 1).

Conclusion

The burden of infections due to gram-negative MDR bacteria is considerably high in patients with hematologic malignancy, with Klebsiella pneumonia being the most predominant causative pathogen. Mortality in these immunocompromised patients remains high and more effort is needed to improve the prognosis of these individuals.

Keyword(s): Hematological malignancy, Infection

Presentation during EHA2021: All e-poster presentations will be made available as of Friday, June 11, 2021 (09:00 CEST) and will be accessible for on-demand viewing until August 15, 2021 on the Virtual Congress platform.

Abstract: EP831

Type: E-Poster Presentation

Session title: Infections in hematology (incl. supportive care/therapy)

Background

Patients with hematologic malignancies are at high risk for infections caused by antibiotic resistant gram-negative bacteria.

Aims

This study aimed to evaluate the characteristics, antibiotic resistance patterns and prognosis of infections due to multidrug resistant (MDR) gram-negative bacteria in patients with hematologic malignancy.

Methods

Data were collected retrospectively and concerned all infections caused by MDR gram-negative in patients with hematologic malignancy from January 2010 and November 2019 in our department of hematology. Data analysis was initially performed using the univariate analysis (chi² and student test). Then, risk factors with a P<0.05 were included in the binary logistic regression model to determine the independent risk factors of mortality.

Results

In Total, 512 patients developed infections with 83 MDR gram-negative strains detected in 80 patients, most of them (68 patients) have an acute leukemia. The MDR gram-negative infection occurred in 58 patients with uncontrolled disease, and the majority of them occurred in the presence of severe neutropenia (62 episodes/74.7%). Bloodstream infection (BSI) (57episodes/68.7%) was the most common infection types. Klebsiella pneumonia was the most common Gram-negative isolates (44 episodes/53%). Complications occurred in 44 (53%) episodes. In 41 episodes, patients received an appropriate antibiotherapy. The isolated MDR gram-negative bacteria exhibited sensitivity to amikacin in 17%, imipenem in 32.5% (three isolates were resistant to colistin). Twenty-two patients died during gram-negative MDR infections. The independent risk factors influencing mortality was : qSOFA>=2. (p : 0.003) (table 1).

Conclusion

The burden of infections due to gram-negative MDR bacteria is considerably high in patients with hematologic malignancy, with Klebsiella pneumonia being the most predominant causative pathogen. Mortality in these immunocompromised patients remains high and more effort is needed to improve the prognosis of these individuals.

Keyword(s): Hematological malignancy, Infection

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies